We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
This page provides a guide for those interested in key upcoming digital regulatory activity being explored, developed or implemented by government. It covers a range of governance activities, from legislative change to the development of co-regulatory and self-regulatory frameworks.
Steps to help grow your business - finding finance, mentors, increasing sales and developing products and services
Guidance for the pharmaceutical industry on how to apply to vary a veterinary Marketing Authorisation (MA) or Homeopathic Remedy.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulations 2024.
Guidance for the pharmaceutical industry on Marketing Authorisations for veterinary medicines in the UK.
Guidance on the decentralised and mutual recognition reliance procedure (MRDCRP) for marketing authorisation applications including information on how to apply.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Find out which country’s VAT rules to use when supplying services abroad.
How to renew marketing authorisations for products granted through different routes and at different times.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Guidance for holders of Marketing Authorisations approved in Northern Ireland or the EU/EEA member states who want to bring a product to market in Great Britain.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The CMA has accepted commitments that address the CMA’s competition concerns regarding Meta’s use of data obtained through digital display advertising.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).